Effect of hypertriglyceridemia on endotoxin responsiveness in humans

T. Van der Poll, C. C. Braxton, S. M. Coyle, M. A. Boermeester, J. C.L. Wang, P. M. Jansen, W. J. Montegut, S. E. Calvano, C. E. Hack, S. F. Lowry

Research output: Contribution to journalArticlepeer-review

46 Scopus citations


Triglyceride-rich lipoproteins can inhibit endotoxin activity in vitro and in rodents. We sought to determine whether Intralipid, a triglyceride-rich fat emulsion which in contact with plasma functions similarly to endogenous lipoproteins, can alter the human response to endotoxin. Intralipid inhibited endotoxin-induced cytokine production in human whole blood in vitro in a dose-dependent manner, with maximal inhibition (up to 70%) being achieved at a concentration of 10 g/liter. In healthy men, a bolus intravenous injection of endotoxin (lot EC-5; 20 U/kg of body weight) was given midway through a 4- h infusion (125 ml/h) of either 5% glucose (n = 5) or 20% Intralipid (n = 5). The infusion of Intralipid led to an increase in triglyceride levels in serum from 95 ± 16 to 818 ± 135 mg/dl prior to endotoxin administration, i.e., levels that importantly reduced cytokine production in endotoxin-stimulated whole blood. However, in vivo hypertriglyceridemia did not influence inflammatory responses to endotoxin (fever, release of tumor necrosis factor and soluble tumor necrosis factor receptors, and leukocytosis) or even potentiated endotoxin responses (release of interleukins 6 and 8 and neutrophil degranulation). Hypertriglyceridemia does not inhibit the in vivo responses to endotoxin in humans.

Original languageEnglish (US)
Pages (from-to)3396-3400
Number of pages5
JournalInfection and Immunity
Issue number9
StatePublished - 1995

ASJC Scopus subject areas

  • Parasitology
  • Microbiology
  • Immunology
  • Infectious Diseases


Dive into the research topics of 'Effect of hypertriglyceridemia on endotoxin responsiveness in humans'. Together they form a unique fingerprint.

Cite this